(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.
The three biggest winners today are AMC, NeuroMetrix, and Groupon.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | AMC (AMC) | 4.65 | 14.81% | 2023-04-06 07:20:37 |
| 2 | NeuroMetrix (NURO) | 1.55 | 10.71% | 2023-04-06 07:22:23 |
| 3 | Groupon (GRPN) | 4.00 | 5.54% | 2023-04-06 07:27:23 |
| 4 | Niu Technologies (NIU) | 3.75 | 3.59% | 2023-04-06 07:33:27 |
| 5 | Gevo (GEVO) | 1.33 | 3.1% | 2023-04-06 06:56:53 |
| 6 | XP (XP) | 11.33 | 3% | 2023-04-06 04:19:55 |
| 7 | Fresenius Medical Care AG (FMS) | 22.26 | 2.63% | 2023-04-06 07:23:21 |
| 8 | Hasbro (HAS) | 53.30 | 2.62% | 2023-04-06 07:12:24 |
| 9 | SmileDirectClub (SDC) | 0.40 | 1.79% | 2023-04-06 07:32:36 |
| 10 | Inovio Pharmaceuticals (INO) | 0.71 | 1.76% | 2023-04-06 07:12:49 |
The three biggest losers today are New York Times, Banco Bradesco, and Tattooed Chef.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | New York Times (NYT) | 37.78 | -2.75% | 2023-04-06 04:17:26 |
| 2 | Banco Bradesco (BBDO) | 2.29 | -2.35% | 2023-04-06 04:10:35 |
| 3 | Tattooed Chef (TTCF) | 1.49 | -1.3% | 2023-04-06 07:22:40 |
| 4 | DouYu (DOYU) | 1.12 | -0.85% | 2023-04-06 07:32:37 |
| 5 | Seattle Genetics (SGEN) | 203.25 | -0.85% | 2023-04-06 04:15:10 |
| 6 | Fox Corporation (FOX) | 30.77 | -0.81% | 2023-04-06 06:26:17 |
| 7 | Emerson Electric Company (EMR) | 82.70 | -0.47% | 2023-04-06 04:13:03 |
| 8 | Wayfair (W) | 34.29 | -0.44% | 2023-04-06 07:20:59 |
| 9 | Canadian Pacific Railway (CP) | 75.51 | -0.33% | 2023-04-06 07:26:59 |
| 10 | Phillips 66 (PSX) | 104.16 | -0.26% | 2023-04-06 07:33:15 |
Premarket Winners today
1. AMC (AMC) – Premarket: 14.81%
AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. As of March 1, 2022, it operated approximately 950 theatres and 10,600 screens. The company was founded in 1920 and is headquartered in Leawood, Kansas.
NYSE ended the session with AMC jumping 3.45% to $4.05 on Thursday, after two sequential sessions in a row of gains. NYSE dropped 0.04% to $15,368.26, after two sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, AMC has a trailing twelve months EPS of $-39.152.
Revenue Growth
Year-on-year quarterly revenue growth grew by 26.9%, now sitting on 4.09B for the twelve trailing months.
Sales Growth
AMC’s sales growth is negative 13.6% for the ongoing quarter and 23.6% for the next.
Yearly Top and Bottom Value
AMC’s stock is valued at $4.05 at 08:34 EST, way under its 52-week high of $34.33 and higher than its 52-week low of $3.77.
Previous days news about AMC
- AMC entertainment stock news: AMC loses 24%, APE gains 18% following conversion settlement. According to FXStreet on Tuesday, 4 April, "Following the special 1 share dividend, there will be 58,841,805 total shares of AMC stock. ", "The agreement means that AMC can now move forward with expanding the limit on its pre-split common shares from "524,173,073 to 550,000,000 shares of Class A common stock" and its plan to effect a 1-for-10 reverse stock split. "
More news about AMC.
2. NeuroMetrix (NURO) – Premarket: 10.71%
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
NASDAQ ended the session with NeuroMetrix falling 3.09% to $1.41 on Thursday while NASDAQ dropped 1.07% to $11,996.86.
Earnings Per Share
As for profitability, NeuroMetrix has a trailing twelve months EPS of $-0.42.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.47%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NeuroMetrix’s stock is considered to be overbought (>=80).
Moving Average
NeuroMetrix’s value is way under its 50-day moving average of $1.71 and way below its 200-day moving average of $2.37.
Volatility
NeuroMetrix’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.80%, a negative 2.00%, and a positive 2.81%.
NeuroMetrix’s highest amplitude of average volatility was 1.84% (last week), 3.16% (last month), and 2.81% (last quarter).
More news about NeuroMetrix.
3. Groupon (GRPN) – Premarket: 5.54%
Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with Groupon dropping 4.42% to $3.79 on Thursday, after three sequential sessions in a row of losses. NASDAQ dropped 1.07% to $11,996.86, after three sequential sessions in a row of losses, on what was an all-around negative trend trading session today.
Earnings Per Share
As for profitability, Groupon has a trailing twelve months EPS of $-10.067.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.5%.
More news about Groupon.
4. Niu Technologies (NIU) – Premarket: 3.59%
Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers NQi, MQi, UQi, and Gova series electric scooters and motorcycles; KQi series electric kick-scooters; NIU Aero and BQi series e-bikes; RQi and TQi series high-performance motorcycles; and YQi series hybrid motorcycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, and smart services, as well as NIU cover, which provides insurance services; NIU Care that offers maintenance and reserve services in offline service stations; and NIU Wash, which provides free wash coupon on a monthly basis. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. As of December 31, 2021, it operated through 338 city partners and 3,108 franchised stores in approximately 239 cities in the People's Republic of China; and 42 distributors in 50 countries internationally. Niu Technologies was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.
NASDAQ ended the session with Niu Technologies dropping 2.95% to $3.62 on Thursday while NASDAQ slid 1.07% to $11,996.86.
Earnings Per Share
As for profitability, Niu Technologies has a trailing twelve months EPS of $0.331.
PE Ratio
Niu Technologies has a trailing twelve months price to earnings ratio of 10.94. Meaning, the purchaser of the share is investing $10.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.77%.
Volatility
Niu Technologies’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.49%, a negative 0.60%, and a positive 3.65%.
Niu Technologies’s highest amplitude of average volatility was 4.65% (last week), 3.45% (last month), and 3.65% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth declined by 6%, now sitting on 3.54B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Niu Technologies’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
Niu Technologies’s stock is valued at $3.62 at 08:34 EST, way under its 52-week high of $11.08 and way above its 52-week low of $2.57.
More news about Niu Technologies.
5. Gevo (GEVO) – Premarket: 3.1%
Gevo, Inc. operates as a renewable fuels company. It operates through four segments: Gevo, Agri-Energy, Renewable Natural Gas, and Net-Zero. The company commercializes gasoline, jet fuel, and diesel fuel to achieve zero carbon emissions, and reduce greenhouse gas emissions with sustainable alternatives. Its products also include renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. Gevo, Inc. has a strategic alliance with Axens North America, Inc. for ethanol-to-jet technology and sustainable aviation fuel commercial project development. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.
NASDAQ ended the session with Gevo sliding 11.38% to $1.29 on Thursday, after five consecutive sessions in a row of losses. NASDAQ dropped 1.07% to $11,996.86, after three successive sessions in a row of losses, on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, Gevo has a trailing twelve months EPS of $-0.706.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.05%.
Volatility
Gevo’s last week, last month’s, and last quarter’s current intraday variation average was a negative 9.31%, a negative 1.85%, and a positive 3.52%.
Gevo’s highest amplitude of average volatility was 9.31% (last week), 5.05% (last month), and 3.52% (last quarter).
More news about Gevo.
6. XP (XP) – Premarket: 3%
XP Inc. provides financial products and services in Brazil. It offers securities brokerage, private pension plans, commercial, and investment banking products, such as loan operations and transactions in the foreign exchange markets and deposits; product structuring and capital markets services for corporate clients and issuers of fixed income products; advisory services for mass-affluent and institutional clients; and wealth management services for high-net-worth customers and institutional clients. The company also offers Xpeed, an online financial education portal that offers seminars, classes, and learning tools to help teach individuals on topics, such as basics of investing, techniques, and investment strategies, as well as insurance brokerage services. In addition, it operates XP Platform, an open product platform that provides clients to access investment products in the market, including equity and fixed income securities, mutual and hedge funds, private equity, structured products, credit cards, loan operations, life insurance, pension plans, real-estate investment funds, and others. The company was founded in 2001 and is based in São Paulo, Brazil.
NASDAQ ended the session with XP rising 0.82% to $11.00 on Thursday while NASDAQ slid 1.07% to $11,996.86.
Earnings Per Share
As for profitability, XP has a trailing twelve months EPS of $0.99.
PE Ratio
XP has a trailing twelve months price to earnings ratio of 11.16. Meaning, the purchaser of the share is investing $11.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.52%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 13.12B for the twelve trailing months.
Sales Growth
XP’s sales growth is 13.1% for the ongoing quarter and 19.4% for the next.
Moving Average
XP’s value is way below its 50-day moving average of $14.42 and way below its 200-day moving average of $17.54.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, XP’s stock is considered to be overbought (>=80).
More news about XP.
7. Fresenius Medical Care AG (FMS) – Premarket: 2.63%
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
NYSE ended the session with Fresenius Medical Care AG rising 1.1% to $21.69 on Thursday, after three successive sessions in a row of gains. NYSE fell 0.04% to $15,368.26, after two consecutive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Fresenius Medical Care AG has a trailing twelve months EPS of $2.39.
PE Ratio
Fresenius Medical Care AG has a trailing twelve months price to earnings ratio of 9.09. Meaning, the purchaser of the share is investing $9.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.66%.
Sales Growth
Fresenius Medical Care AG’s sales growth is 10.1% for the current quarter and 9.6% for the next.
Yearly Top and Bottom Value
Fresenius Medical Care AG’s stock is valued at $21.69 at 08:34 EST, way under its 52-week high of $34.65 and way above its 52-week low of $12.79.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 12, 2022, the estimated forward annual dividend rate is 0.71 and the estimated forward annual dividend yield is 3.66%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 48.9% and a negative 28.6%, respectively.
More news about Fresenius Medical Care AG.
8. Hasbro (HAS) – Premarket: 2.62%
Hasbro, Inc., together with its subsidiaries, operates as a play and entertainment company. Its Consumer Products segment engages in the sourcing, marketing, and sale of toy and game products. This segment also promotes its brands through the out-licensing of trademarks, characters, and other brand and intellectual property rights to third parties through the sale of branded consumer products, such as toys and apparels. Its toys and games include action figures, arts and crafts and creative play products, fashion and other dolls, play sets, preschool toys, plush products, sports action blasters and accessories, vehicles and toy-related specialty products, games, and other consumer products; and licensed products, such as apparels, publishing products, home goods and electronics, and toy products. The company's Wizards of the Coast and Digital Gaming segment engages in the promotion of its brands through the development of trading card, role-playing, and digital game experiences based on Hasbro and Wizards of the Coast games. Its Entertainment segment engages in the development, acquisition, production, distribution, and sale of world-class entertainment content, including film, scripted and unscripted television, family programming, digital content, and live entertainment. The company sells its products to retailers, distributors, wholesalers, discount stores, drug stores, mail order houses, catalog stores, department stores, and other traditional retailers, as well as ecommerce retailers; and directly to customer through Hasbro PULSE e-commerce website. Hasbro, Inc. was founded in 1923 and is headquartered in Pawtucket, Rhode Island.
NASDAQ ended the session with Hasbro falling 0.83% to $51.94 on Thursday while NASDAQ fell 1.07% to $11,996.86.
Earnings Per Share
As for profitability, Hasbro has a trailing twelve months EPS of $2.97.
PE Ratio
Hasbro has a trailing twelve months price to earnings ratio of 17.51. Meaning, the purchaser of the share is investing $17.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.7%.
More news about Hasbro.
9. SmileDirectClub (SDC) – Premarket: 1.79%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub falling 2.18% to $0.39 on Thursday, after five successive sessions in a row of losses. NASDAQ slid 1.07% to $11,996.86, after three sequential sessions in a row of losses, on what was an all-around negative trend trading session today.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.334.
Volume
Today’s last reported volume for SmileDirectClub is 241939 which is 90.35% below its average volume of 2509520.
Sales Growth
SmileDirectClub’s sales growth is negative 28.2% for the present quarter and negative 27.2% for the next.
Volatility
SmileDirectClub’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.44%, a negative 1.60%, and a positive 6.13%.
SmileDirectClub’s highest amplitude of average volatility was 6.55% (last week), 3.92% (last month), and 6.13% (last quarter).
More news about SmileDirectClub.
10. Inovio Pharmaceuticals (INO) – Premarket: 1.76%
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
NASDAQ ended the session with Inovio Pharmaceuticals falling 2.32% to $0.70 on Thursday while NASDAQ dropped 1.07% to $11,996.86.
Earnings Per Share
As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-1.073.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -92.27%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3038.2%, now sitting on 10.98M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 66% and 52.8%, respectively.
More news about Inovio Pharmaceuticals.
Premarket Losers Today
1. New York Times (NYT) – Premarket: -2.75%
The New York Times Company, together with its subsidiaries, provides news and information for readers and viewers across various platforms worldwide. It offers The New York Times (The Times), a daily and Sunday newspaper in the United States, as well as international edition of The Times; and operates the NYTimes.com Website. The company also transmits articles, graphics, and photographs from The Times and other publications to approximately 1,500 newspapers, magazines, and websites; licenses electronic databases to resellers in the business, professional, and library markets; and offers magazine licensing, news digests, book development, and rights and permissions. In addition, it engages in the live events business, which hosts physical and virtual live events to connect audiences with journalists and outside thought leaders; direct-sold website, mobile application, podcast, email, and video advertisements, as well as digital advertising services; operates Wirecutter, a product review and recommendation products; develops mobile applications, including games and cooking products; prints and distributes products for third parties; and offers other products and services. The company was founded in 1851 and is headquartered in New York, New York.
NYSE ended the session with New York Times jumping 0.03% to $38.85 on Thursday while NYSE fell 0.04% to $15,368.26.
Earnings Per Share
As for profitability, New York Times has a trailing twelve months EPS of $0.6.
PE Ratio
New York Times has a trailing twelve months price to earnings ratio of 64.75. Meaning, the purchaser of the share is investing $64.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.28%.
Yearly Top and Bottom Value
New York Times’s stock is valued at $38.85 at 08:34 EST, way below its 52-week high of $47.67 and way above its 52-week low of $27.59.
Volatility
New York Times’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.84%, a negative 0.02%, and a positive 1.40%.
New York Times’s highest amplitude of average volatility was 1.22% (last week), 1.40% (last month), and 1.40% (last quarter).
More news about New York Times.
2. Banco Bradesco (BBDO) – Premarket: -2.35%
Banco Bradesco S.A., together with its subsidiaries, provides various banking products and services to individuals, corporates, and businesses in Brazil and internationally. The company operates through two segments, Banking and Insurance. It provides current, savings, click, and salary accounts; real estate credit, vehicle financing, payroll loans, mortgage loans, microcredit, leasing, and personal and installment credit; debit and business cards; financial and security services; consortium products; auto, personal accident, dental, travel, and life insurance; investment products; pension products; real estate and vehicle auctions; cash management, and foreign trade and exchange services; capitalization bonds; and internet banking services. Banco Bradesco S.A. was founded in 1943 and is headquartered in Osasco, Brazil. Banco Bradesco S.A. is a subsidiary of Cidade de Deus – Companhia Comercial de Participações.
NYSE ended the session with Banco Bradesco rising 2.17% to $2.35 on Thursday while NYSE dropped 0.04% to $15,368.26.
Earnings Per Share
As for profitability, Banco Bradesco has a trailing twelve months EPS of $0.299.
PE Ratio
Banco Bradesco has a trailing twelve months price to earnings ratio of 7.86. Meaning, the purchaser of the share is investing $7.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.02%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Banco Bradesco’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 95.5B for the twelve trailing months.
Moving Average
Banco Bradesco’s worth is under its 50-day moving average of $2.36 and way below its 200-day moving average of $2.72.
Volume
Today’s last reported volume for Banco Bradesco is 22934 which is 14.75% below its average volume of 26903.
More news about Banco Bradesco.
3. Tattooed Chef (TTCF) – Premarket: -1.3%
Tattooed Chef, Inc., a plant-based food company, produces and sells a portfolio of frozen foods. It supplies plant-based products to retailers in the United States. The company offers ready-to-cook bowls, zucchini spirals, riced cauliflower, acai and smoothie bowls, cauliflower crust pizza, and plant-based burgers. Its products are available in private label and Tattooed Chef brand name in the frozen food section of retail food stores. As of December 31, 2021, it operated approximately 14,000 retail outlets. Tattooed Chef, Inc. is headquartered in Paramount, California.
NASDAQ ended the session with Tattooed Chef dropping 0.66% to $1.51 on Thursday, after four successive sessions in a row of losses. NASDAQ dropped 1.07% to $11,996.86, after three consecutive sessions in a row of losses, on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, Tattooed Chef has a trailing twelve months EPS of $-0.069.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.72%.
Volume
Today’s last reported volume for Tattooed Chef is 337986 which is 66.48% below its average volume of 1008360.
More news about Tattooed Chef.
4. DouYu (DOYU) – Premarket: -0.85%
DouYu International Holdings Limited, together with its subsidiaries, operates a platform on PC and mobile apps that provides interactive games and entertainment live streaming services in the People's Republic of China. Its platform connects game developers and publishers, professional eSports teams or players and eSports tournament organizers, advertisers, and viewers. The company also sponsors eSports teams and organizes eSports tournaments. In addition, it streams other content to include a spectrum of live streaming entertainment options, such as talent shows, music, outdoor, and travel. Further, the company records and offers video clips to allow users to watch replays of selective live streaming content; and allows viewers and streamers to edit and upload short video clips by themselves. DouYu International Holdings Limited was founded in 2014 and is headquartered in Wuhan, the People's Republic of China.
NASDAQ ended the session with DouYu falling 3.02% to $1.13 on Thursday, after five sequential sessions in a row of losses. NASDAQ dropped 1.07% to $11,996.86, after three sequential sessions in a row of losses, on what was an all-around negative trend trading session today.
Earnings Per Share
As for profitability, DouYu has a trailing twelve months EPS of $-0.255.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.93%.
Yearly Top and Bottom Value
DouYu’s stock is valued at $1.13 at 08:34 EST, way under its 52-week high of $2.48 and way higher than its 52-week low of $0.90.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DouYu’s stock is considered to be overbought (>=80).
More news about DouYu.
5. Seattle Genetics (SGEN) – Premarket: -0.85%
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.
NASDAQ ended the session with Seattle Genetics jumping 0.05% to $205.00 on Thursday, after two consecutive sessions in a row of gains. NASDAQ fell 1.07% to $11,996.86, after three sequential sessions in a row of losses, on what was an all-around bearish trend exchanging session today.
Earnings Per Share
As for profitability, Seattle Genetics has a trailing twelve months EPS of $3.58.
PE Ratio
Seattle Genetics has a trailing twelve months price to earnings ratio of 57.2. Meaning, the purchaser of the share is investing $57.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.27%.
More news about Seattle Genetics.
6. Fox Corporation (FOX) – Premarket: -0.81%
Fox Corporation operates as a news, sports, and entertainment company in the United States (U.S.). The company operates through Cable Network Programming; Television; and Other, Corporate and Eliminations segments. The Cable Network Programming segment produces and licenses news, business news, and sports content for distribution through traditional and virtual multi-channel video programming distributors (MVPDs) and other digital platforms, primarily in the U.S. It operates FOX News, a national cable news channel; FOX Business, a business news national cable channel; FS1 and FS2 multi-sport national networks; FOX Sports Racing, a video programming service that comprises motor sports programming; FOX Soccer Plus, a video programming network for live soccer and rugby competitions; FOX Deportes, a Spanish-language sports programming service; and Big Ten Network, a national video programming service. The Television segment acquires, produces, markets, and distributes programming. It operates The FOX Network, a national television broadcast network that broadcasts sports programming and entertainment; Tubi, an advertising-supported video-on-demand service; Fox Alternative Entertainment, a full-service production studio that develops and produces unscripted and alternative programming; MyNetworkTV, a programming distribution service; and Blockchain Creative Labs, which is focuses on the creation, distribution and monetization of Web3 content. This segment owns and operates 29 broadcast television stations. The Other, Corporate and Eliminations segment owns the FOX Studios Lot that provides production and post-production services, including 15 sound stages, two broadcast studios, theaters and screening rooms, editing rooms, and other television and film production facilities in Los Angeles, California. The company was incorporated in 2018 and is based in New York, New York.
NASDAQ ended the session with Fox Corporation falling 0.43% to $31.02 on Thursday, after two successive sessions in a row of losses. NASDAQ fell 1.07% to $11,996.86, after three sequential sessions in a row of losses, on what was an all-around negative trend trading session today.
Earnings Per Share
As for profitability, Fox Corporation has a trailing twelve months EPS of $2.53.
PE Ratio
Fox Corporation has a trailing twelve months price to earnings ratio of 12.28. Meaning, the purchaser of the share is investing $12.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.13%.
Volume
Today’s last reported volume for Fox Corporation is 461791 which is 61.65% below its average volume of 1204340.
Yearly Top and Bottom Value
Fox Corporation’s stock is valued at $31.02 at 08:34 EST, way below its 52-week high of $37.06 and way higher than its 52-week low of $26.35.
More news about Fox Corporation.
7. Emerson Electric Company (EMR) – Premarket: -0.47%
Emerson Electric Co., a technology and engineering company, provides various solutions for customers in industrial, commercial, and consumer markets in the Americas, Asia, the Middle East, Africa, and Europe. The company operates through Automation Solutions, AspenTech, and Commercial & Residential Solutions segments. The Automation Solutions segment offers measurement and analytical instrumentation, industrial valves and equipment, and process control software and systems. It serves oil and gas, refining, chemicals, power generation, life sciences, food and beverage, automotive, pulp and paper, metals and mining, and municipal water supplies markets. The AspenTech segment provides asset optimization software that enables industrial manufacturers to design, operate, and maintain their operations for enhancing performance through a combination of decades of modeling, simulation, and optimization capabilities. The Commercial & Residential Solutions segment offers residential and commercial heating and air conditioning products, such as reciprocating and scroll compressors; system protector and flow control devices; standard, programmable, and Wi-Fi thermostats; monitoring equipment and electronic controls for gas and electric heating systems; gas valves for furnaces and water heaters; ignition systems for furnaces; and temperature sensors and controls. It also provides reciprocating, scroll, and screw compressors; precision flow controls; system diagnostics and controls; and environmental control systems. In addition, this segment offers air conditioning, refrigeration, and lighting control technologies, as well as facility design and product management, site commissioning, facility monitoring, and energy modeling services; and tools for professionals and homeowners. The company was incorporated in 1890 and is headquartered in Saint Louis, Missouri.
NYSE ended the session with Emerson Electric Company dropping 2.46% to $83.09 on Thursday, after two sequential sessions in a row of losses. NYSE fell 0.04% to $15,368.26, after two sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Emerson Electric Company has a trailing twelve months EPS of $3.45.
PE Ratio
Emerson Electric Company has a trailing twelve months price to earnings ratio of 24.05. Meaning, the purchaser of the share is investing $24.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.8%.
More news about Emerson Electric Company.
8. Wayfair (W) – Premarket: -0.44%
Wayfair Inc. engages in the e-commerce business in the United States and internationally. The company provides approximately thirty-three million products for the home sector under various brands. It offers online selections of furniture, décor, housewares, and home improvement products through its sites, including Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold brands. The company was founded in 2002 and is headquartered in Boston, Massachusetts.
NYSE ended the session with Wayfair falling 3.89% to $34.44 on Thursday, after four successive sessions in a row of losses. NYSE dropped 0.04% to $15,368.26, after two consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Wayfair has a trailing twelve months EPS of $1.86.
PE Ratio
Wayfair has a trailing twelve months price to earnings ratio of 18.52. Meaning, the purchaser of the share is investing $18.52 for every dollar of annual earnings.
Moving Average
Wayfair’s value is way below its 50-day moving average of $47.00 and way below its 200-day moving average of $45.97.
Sales Growth
Wayfair’s sales growth is negative 5.9% for the present quarter and negative 5.5% for the next.
Volatility
Wayfair’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.37%, a negative 0.27%, and a positive 5.26%.
Wayfair’s highest amplitude of average volatility was 3.39% (last week), 3.03% (last month), and 5.26% (last quarter).
Yearly Top and Bottom Value
Wayfair’s stock is valued at $34.44 at 08:34 EST, way below its 52-week high of $130.58 and way higher than its 52-week low of $28.11.
More news about Wayfair.
9. Canadian Pacific Railway (CP) – Premarket: -0.33%
Canadian Pacific Railway Limited, together with its subsidiaries, owns and operates a transcontinental freight railway in Canada and the United States. The company transports bulk commodities, including grain, coal, potash, fertilizers, and sulphur; and merchandise freight, such as energy, chemicals and plastics, metals, minerals and consumer, automotive, and forest products. It also transports intermodal traffic comprising retail goods in overseas containers. The company offers rail and intermodal transportation services through a network of approximately 13,000 miles serving business centers in Quebec and British Columbia, Canada; and the United States Northeast and Midwest regions. Canadian Pacific Railway Limited was incorporated in 1881 and is headquartered in Calgary, Canada.
NYSE ended the session with Canadian Pacific Railway falling 1.85% to $75.76 on Thursday while NYSE dropped 0.04% to $15,368.26.
Earnings Per Share
As for profitability, Canadian Pacific Railway has a trailing twelve months EPS of $15.89.
PE Ratio
Canadian Pacific Railway has a trailing twelve months price to earnings ratio of 4.77. Meaning, the purchaser of the share is investing $4.77 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.67%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 46% and 26.1%, respectively.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 29, 2023, the estimated forward annual dividend rate is 0.57 and the estimated forward annual dividend yield is 0.74%.
More news about Canadian Pacific Railway.
10. Phillips 66 (PSX) – Premarket: -0.26%
Phillips 66 operates as an energy manufacturing and logistics company. It operates through four segments: Midstream, Chemicals, Refining, and Marketing and Specialties (M&S). The Midstream segment transports crude oil and other feedstocks; delivers refined petroleum products to market; provides terminaling and storage services for crude oil and refined petroleum products; transports, stores, fractionates, exports, and markets natural gas liquids; provides other fee-based processing services; and gathers, processes, transports, and markets natural gas. The Chemicals segment produces and markets ethylene and other olefin products; aromatics and styrenics products, such as benzene, cyclohexane, styrene, and polystyrene; and various specialty chemical products, including organosulfur chemicals, solvents, catalysts, and chemicals used in drilling and mining. The Refining segment refines crude oil and other feedstocks into petroleum products, such as gasolines, distillates, aviation, and renewable fuels at 12 refineries in the United States and Europe. The M&S segment purchases for resale and markets refined petroleum products, including gasolines, distillates, and aviation fuels primarily in the United States and Europe. This segment also manufactures and markets specialty products, such as base oils and lubricants. The company was founded in 1875 and is headquartered in Houston, Texas.
NYSE ended the session with Phillips 66 jumping 6.25% to $104.43 on Thursday, after two successive sessions in a row of gains. NYSE dropped 0.04% to $15,368.26, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Phillips 66 has a trailing twelve months EPS of $-4.88.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.46%.
Previous days news about Phillips 66
- Why it is worth buying phillips 66 (psx) stock right away. According to Zacks on Wednesday, 5 April, "In each of the operations, Phillips 66 has a good footprint pertaining to safety, profitability, size and competitive strengths.", "Thus, with a robust midstream business portfolio, Phillips 66 will generate stable cashflows with lower exposure to energy business volatility."
More news about Phillips 66.
Stay up to date with our premarket winners and losers daily report
